http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6147449-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cfc033f059d282fcd915bc8be2ae53f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-22
filingDate 1984-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b7bdecc899dd709d44cec5ead9afb9b
publicationDate 1986-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6147449-A
titleOfInvention Preparation of hydroxythreonine
abstract PURPOSE: To obtain a compound useful as various synthetic intermediates for antibiotics, etc. in one-stage reaction operation, by reacting glycine with glycolaldehyde in the presence of a basic substance and a catalyst. n CONSTITUTION: Glycine is reacted with glycolaldehyde in the presence of a basic substance, e.g. an alkali metal hydroxide or alkali metal carbonate, and a salt of copper, nickel, iron or zinc, etc. in a solvent, e.g. methanol, at 0W60°C to give the aimed substance. The molar amount of the glycolaldehyde to be used is equimolar amount or 5 times the molar amount of the glycine, and the amount of the basic substance to be used is 1/10W2 times the equivalent amount of the glycine. n COPYRIGHT: (C)1986,JPO&Japio
priorityDate 1984-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49852420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419563406
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425769382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412550040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418354341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887

Total number of triples: 30.